Hesketh PJ - Search Results

1

Serotonin antagonists: a new class of antiemetic agents.

Hesketh PJ, Gandara DR. Hesketh PJ, et al. J Natl Cancer Inst. 1991 May 1;83(9):613-20. doi: 10.1093/jnci/83.9.613. J Natl Cancer Inst. 1991. PMID: 1850806

2

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.

Hainsworth J, Harvey W, Pendergrass K, Kasimis B, Oblon D, Monaghan G, Gandara D, Hesketh P, Khojasteh A, Harker G, et al. Hainsworth J, et al. J Clin Oncol. 1991 May;9(5):721-8. doi: 10.1200/JCO.1991.9.5.721. J Clin Oncol. 1991. PMID: 1826739 Clinical Trial.

3

Serotonin antagonists in the management of cisplatin-induced emesis.

Perez EA, Hesketh PJ, Gandara DR. Perez EA, et al. Among authors: hesketh pj. Semin Oncol. 1991 Feb;18(1 Suppl 3):73-80. Semin Oncol. 1991. PMID: 2003230 Review.

4

GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.

Hesketh PJ, Murphy WK, Lester EP, Gandara DR, Khojasteh A, Tapazoglou E, Sartiano GP, White DR, Werner K, Chubb JM. Hesketh PJ, et al. J Clin Oncol. 1989 Jun;7(6):700-5. doi: 10.1200/JCO.1989.7.6.700. J Clin Oncol. 1989. PMID: 2523957 Clinical Trial.

5

Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo.

Gandara DR, Harvey WH, Monaghan GG, Perez EA, Hesketh PJ. Gandara DR, et al. Among authors: hesketh pj. Eur J Cancer. 1993;29A Suppl 1:S35-8. doi: 10.1016/s0959-8049(05)80259-x. Eur J Cancer. 1993. PMID: 8427724 Clinical Trial.

6

Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide.

Hesketh PJ, Gandara DR, Hesketh AM, Facada A, Perez EA, Webber LM, Martin LA, Cramer MB, Hahne WF. Hesketh PJ, et al. Among authors: hesketh am. Support Care Cancer. 1996 Mar;4(2):141-6. doi: 10.1007/BF01845763. Support Care Cancer. 1996. PMID: 8673351 Clinical Trial.

7

Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.

Hesketh PJ, Gandara DR, Hesketh AM, Edelman M, Webber LM, McManus M, Hainsworth JD. Hesketh PJ, et al. Among authors: hesketh am. Cancer J Sci Am. 1997 May-Jun;3(3):180-3. Cancer J Sci Am. 1997. PMID: 9161784 Clinical Trial.

8

Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.

Hesketh PJ, Crowley JJ, Burris HA 3rd, Williamson SK, Balcerzak SP, Peereboom D, Goodwin JW, Gross HM, Moore DF Jr, Livingston RB, Gandara DR. Hesketh PJ, et al. Cancer J Sci Am. 1999 Jul-Aug;5(4):237-41. Cancer J Sci Am. 1999. PMID: 10439170 Clinical Trial.

9

Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.

Hesketh PJ, Roman A, Hesketh AM, Perez EA, Edelman M, Gandara DR. Hesketh PJ, et al. Among authors: hesketh am. Support Care Cancer. 2000 Jan;8(1):46-8. doi: 10.1007/s005209900077. Support Care Cancer. 2000. PMID: 10650897 Clinical Trial.

10

Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer.

Hesketh PJ, Nauman CJ, Hesketh AM, LaPointe J, Fogarty K, Oo TH, Lau DH, Edelman MJ, Gandara DR. Hesketh PJ, et al. Among authors: hesketh am. Clin Lung Cancer. 2002 Jul;4(1):47-51. doi: 10.3816/clc.2002.n.015. Clin Lung Cancer. 2002. PMID: 14653876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters